Introduction: Given the increasing number of older patients undergoing allo-HCT with post-transplant cyclophosphamide (PTCy)-based prophylaxis, a dedicated evaluation of its safety in this population ...
Lynozyfic showed a 79% overall response rate in newly diagnosed multiple myeloma, with 86% in the 200 mg dose group. Rapid responses were observed, with a median time to partial response of 1.2 months ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Baltimore Orioles starting pitcher John Means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback